Holdings
Mpm Bioimpact LLC
As of Sep 30, 2026, Mpm Bioimpact LLC reported 34 positions worth US$1.23B. Largest: Cullinan Therapeutics, Inc., Aktis Oncology, Inc. and Travere Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Cullinan Therapeutics, Inc. | 9.72M | US$149M | −10,260 | Sep 30, 2026 |
| Aktis Oncology, Inc. | 4.84M | US$94.2M | no change | Sep 30, 2026 |
| Travere Therapeutics, Inc. | 1.09M | US$64.1M | −34,368 | Sep 30, 2026 |
| Edgewise Therapeutics, Inc. | 1.58M | US$64M | −44,793 | Sep 30, 2026 |
| Dyne Therapeutics, Inc. | 3.21M | US$51.7M | +1.29M | Sep 30, 2026 |
| Corcept Therapeutics Incorporated | 422K | US$48.6M | −349K | Sep 30, 2026 |
| Relay Therapeutics, Inc. | 2.37M | US$42.8M | −46,094 | Sep 30, 2026 |
| Trevi Therapeutics, Inc. | 2.98M | US$42.7M | −94,671 | Sep 30, 2026 |
| Iovance Biotherapeutics, Inc. | 2.84M | US$42M | new | Sep 30, 2026 |
| Liquidia Corporation | 1.34M | US$40.6M | −43,461 | Sep 30, 2026 |